Founded
Address
Other Office
601 Union Street
Suite 3200, Two Union Square
Seattle, WA 98101
United States
Phone
Website
Recent investment activity
KANDO id: 30603
Company type
Investment firm providing growth and venture capital to healthcare companies.Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 76 - 99 of 99| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
|
Zeltiq Aesthetics Inc | N/A | ||||
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Zonare Medical Systems Inc | N/A | ||||
|
Achaogen Inc | Develops solutions to the problem of drug resistance | N/A Initial investment | |||
|
|
ActivX Biosciences Inc | Discoverer and developer of highly selective, best in class, small molecule drugs for major unmet medical needs. | N/A | |||
|
|
Alcresta Inc | Developing and commercializing innovative enzyme-based nutritional products | N/A | |||
|
|
Alexza Pharmaceuticals Inc | N/A Initial investment | ||||
|
|
Allena Pharmaceuticals Inc | Developing and Commercializing Innovative Non-systemic Oral Protein Therapeutics | N/A | |||
|
|
Alnara Pharmaceuticals Inc | N/A | ||||
|
|
Amicus Therapeutics Inc | N/A Initial investment | ||||
|
|
AnaptysBio Inc | Antibody therapeutics company focusing on antibody discovery and optimization. | N/A | |||
|
|
Array BioPharma Inc | N/A | ||||
|
|
Barrx Medical Inc | Minimally invasive placed single use disposable medical device for the treatment of Barrett’s esophagus. | Series D | |||
|
|
Barrx Medical Inc | Minimally invasive placed single use disposable medical device for the treatment of Barrett’s esophagus. | N/A | |||
|
|
Bravo Health Inc | N/A Initial investment | ||||
|
|
Calistoga Pharmaceuticals Inc | Biopharmaceutical company dedicated to developing targeted therapies to improve the health of patients with cancer or inflammatory diseases. | Series A | |||
|
|
Calypso Medical Technologies Inc | A medical device company developing innovative tools and therapies for the oncology marketa advancing cancer radiation treatment. | Series E led the round | |||
|
|
Calypso Medical Technologies Inc | A medical device company developing innovative tools and therapies for the oncology marketa advancing cancer radiation treatment. | Series D | |||
|
|
Calypso Medical Technologies Inc | A medical device company developing innovative tools and therapies for the oncology marketa advancing cancer radiation treatment. | Series C | |||
|
|
Clovis Oncology Inc | Series A | ||||
|
|
Portola Pharmaceuticals Inc | N/A | ||||
|
|
Rempex Pharmaceuticals Inc | Rempex Pharmaceuticals, Inc. is a San Diego-based pharmaceutical company. | Series B Initial investment | |||
|
|
XenoPort Inc | N/A Initial investment | ||||
|
|
Zelos Therapeutics Inc | N/A | ||||
|
ZymoGenetics Inc | Discovery, development and commercialization of therapeutic proteins for the prevention and treatment of human diseases. | N/A |